Search
-
Predicting Opportunity in Emerging Therapies
The advent of groundbreaking therapies in the metabolic sector, including GLP-1, offers substantial opportunities for pharmaceutical companies, yet accurately estimating the size of these emerging markets, marked by significant unmet clinical needs, presents distinct challenges.
-
Ipsos Health Service Report 2024: Mental Health seen as the biggest Health issue
Across 31 countries 44% rate the quality of the healthcare they receive as good, but access to treatment and not enough staff are seen as major systemic challenges
-
Ipsos Update – September 2024
Data, Healthcare, Education … Ipsos Update explores the latest and research & thinking on key topics from Ipsos teams around the world.
-
Rare Diseases: A Diagnostic Odyssey
Unravelling the Complexities of Rare Diseases: A Market Research Perspective
-
Launch of Ipsos PersonaBot, a groundbreaking AI-powered solution to enhance segmentation research
Ipsos has launched Ipsos PersonaBot. This AI-powered tool, powered by Ipsos Facto, allows organizations to engage in conversations with personas representing their target audience. Ipsos PersonaBot is available for both consumer and healthcare sectors.
-
Ipsos Update – July 2024
AI, Refugees, Crime … Ipsos Update explores the latest and research & thinking on key topics from Ipsos teams around the world.